Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Gross Margin Growth (1y) (2019 - 2026)

Analysis

Verastem (VSTM) Gross Margin Growth (1y) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -93.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -91.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 210.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1,966.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 228.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -475.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1,034.00
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn 549.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 549.00
Dec 31, 2020 681.00
Sep 30, 2020 301.00
Jun 30, 2020 292.00
Mar 31, 2020 -33.00
Dec 31, 2019 41.00
Sep 30, 2019 -379.00